MICHAEL D. BLASZYK - 10 Jun 2021 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role
Director
Signature
/s/ Sonja Nelson, as Attorney-in-Fact
Issuer symbol
IBRX
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
14 Jun 2021, 18:31:22 UTC
Next filing
26 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBRX Stock Option (right to buy) Award $0 +26,064 $0.000000 26,064 10 Jun 2021 Common Stock 26,064 $14.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2022 or the date immediately preceding the 2022 annual meeting of stockholders.